These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17931075)

  • 21. Impact of Modified System of Objectified Judgement Analysis (SOJA) methodology on prescribing costs of ACE inhibitors.
    Alabbadi I; Crealey G; Scott M; Baird S; Trouton T; Mairs J; McElnay J
    Clin Drug Investig; 2006; 26(9):485-94. PubMed ID: 17163281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Marketed oral triptans in the acute treatment of migraine: a systematic review on efficacy and tolerability.
    Pascual J; Mateos V; Roig C; Sanchez-Del-Rio M; Jiménez D
    Headache; 2007 Sep; 47(8):1152-68. PubMed ID: 17883520
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An economic evaluation of rizatriptan in the treatment of migraine.
    Thompson M; Gawel M; Desjardins B; Ferko N; Grima D
    Pharmacoeconomics; 2005; 23(8):837-50. PubMed ID: 16097844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hair analysis for detection of triptans occasionally used or overused by migraine patients-a pilot study.
    Ferrari A; Baraldi C; Licata M; Vandelli D; Marchesi F; Palazzoli F; Verri P; Rustichelli C; Giuliani E; Silingardi E
    Eur J Clin Pharmacol; 2016 Sep; 72(9):1075-81. PubMed ID: 27245458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of the use of triptans in acute migraine.
    Gawel MJ; Worthington I; Maggisano A
    Can J Neurol Sci; 2001 Feb; 28(1):30-41. PubMed ID: 11252291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of almotriptan 12.5 mg in achieving migraine-related composite endpoints: a double-blind, randomized, placebo-controlled study in patients controlled study in patients with previous poor response to sumatriptan 50 mg.
    Diener HC
    Curr Med Res Opin; 2005 Oct; 21(10):1603-10. PubMed ID: 16238900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health outcomes evaluations: estimating the impact of almotriptan in managed care settings.
    Mayo KW; Osterhaus JT
    Am J Manag Care; 2002 Feb; 8(3 Suppl):S85-93. PubMed ID: 11859909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in Prescription Drug Coverage for Triptans: Analysis of Insurance Formularies.
    Minen MT; Lindberg K; Langford A; Loder E
    Headache; 2017 Sep; 57(8):1243-1251. PubMed ID: 28691382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis.
    Cameron C; Kelly S; Hsieh SC; Murphy M; Chen L; Kotb A; Peterson J; Coyle D; Skidmore B; Gomes T; Clifford T; Wells G
    Headache; 2015; 55 Suppl 4():221-35. PubMed ID: 26178694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC; Ashcroft DM
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of almotriptan malate for migraine.
    Balbisi EA
    Am J Health Syst Pharm; 2002 Nov; 59(22):2184-93. PubMed ID: 12455302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using patient-centered endpoints to determine the cost-effectiveness of triptans for acute migraine therapy.
    Kelman L; Von Seggern RL
    Am J Ther; 2006; 13(5):411-7. PubMed ID: 16988536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Triptans other than sumatriptan in child and adolescent migraine: literature review.
    Vollono C; Vigevano F; Tarantino S; Valeriani M
    Expert Rev Neurother; 2011 Mar; 11(3):395-401. PubMed ID: 21375444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
    Lipton RB; Pascual J; Goadsby PJ; Massiou H; McCarroll KA; Vandormael K; Jiang K; Lines CR
    Headache; 2001 Sep; 41(8):754-63. PubMed ID: 11576198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP; Gawel M
    Drugs; 2003; 63(21):2285-305. PubMed ID: 14524731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network meta-analysis of migraine disorder treatment by NSAIDs and triptans.
    Xu H; Han W; Wang J; Li M
    J Headache Pain; 2016 Dec; 17(1):113. PubMed ID: 27957624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluoroquinolones: use of clinical data to aid formulary choice by the system of objective judgement analysis (SOJA) method.
    Janknegt R
    Pharmacoeconomics; 1994 Jul; 6(1):15-33. PubMed ID: 10147351
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Economic evaluation of acute migraine attack treatment with triptans in Spain].
    Gracia-Naya M; Rejas Gutiérrez J; Latorre Jiménez A; González Garcia P
    Neurologia; 2005 Apr; 20(3):121-32. PubMed ID: 15815947
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of multiattribute decision models in evaluating triptan treatment options in migraine.
    Ferrari MD; Goadsby PJ; Lipton RB; Dodick DW; Cutrer FM; McCrory D; Williams P
    J Neurol; 2005 Sep; 252(9):1026-32. PubMed ID: 15761676
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.